Public health campaigns, diabetes education programs, and the role of healthcare providers in educating patients about the importance of medication adherence have contributed to a more informed patient population
UK Summaries of Product Characteristics (SmPCs) advise caution in people with a history of pancreatitis, severe gastrointestinal disease, or thyroid disease
Cost is the driving factor
The site of absorption has been reported to be the stomach ( Although there are GLP-1 receptors in the stomach wall, these appear to be mechanoreceptors, and control local motility of the gastric tissue, rather than being involved in direct messaging to the brain ( The Axcess formulation was originally developed by Diabetology in 2003, and recent improvements have increased efficacy further, increasing the scope of the associated intellectual property, and providing cover out to 2040 and beyond
It covers every dose from the starting 0.25mg (5 units) all the way to 2.5mg (50 units)
Real results documentation, like the kind seen in clinical trials for semaglutide or tirzepatide , includes controlled conditions, standardized photography, and published methodology